Market Place
Sourcing Support
Xcelerate, Inc. Announces Funding
31 Oct 2024 //
ACCESSWIRE
Xcelerate, Inc. Launches Ceramedx TikTok Skincare Campaign
23 Oct 2024 //
ACCESSWIRE
Xcelerate, Inc. Issues Shareholder Update
15 Oct 2024 //
ACCESSWIRE
Xcelerate Starts Nationalization Of PCT International Patent Applications
22 Aug 2024 //
ACCESSWIRE
Xcelerate Retains Craft For Investment Banking, Uplisting Advisory
06 Jun 2024 //
ACCESSWIRE
Xcelerate, Inc. Addresses Concerns About Recently Released Research Report
04 Jun 2024 //
ACCESSWIRE
Xcelerate, Inc. Announces Change of Auditors
13 May 2024 //
ACCESSWIRE
Xcelerate, Inc. Announces That It Has Filed Its 2023 Annual Report
30 Apr 2024 //
ACCESSWIRE
Xcelerate: ESN Live on Army & Air Force Exchange Online
25 Apr 2024 //
ACCESSWIRE
Xcelerate Engages Leading Investor Relations Firm Darrow Associates
25 Mar 2024 //
ACCESSWIRE
Xcelerate, Inc. Announces Publication of its Two Utility Patent Applications
24 Oct 2023 //
ACCESSWIRE
Xcelerate, Inc. Announces that ESN Group, Inc. Has Been Approved as a Vendor
14 Sep 2023 //
ACCESSWIRE
Xcelerate, Inc. Announces Interview With CEO Michael O`Shea
08 Jun 2023 //
ACCESSWIRE
Xcelerate Announces Agreement to Acquire a Controlling Interest in ESN, Inc.
12 Apr 2023 //
ACCESSWIRE
Xcelerate Announces Afya Signs Agreement with National Hospital of Tanzania
14 Mar 2023 //
ACCESSWIRE
Fabian Urquijo Joins the Advisory Board of Xcelerate, Inc.
01 Feb 2023 //
ACCESSWIRE
Xcelerate Inc. to Acquire Controlling Interest in ESN Group, Inc
17 Jan 2023 //
ACCESSWIRE
Copyright © 2025 LePro PharmaCompass OPC Private Limited, All rights reserved.